Enhanced CTLA-4 blockade anti-tumor immunity with APG-157 combination in a murine head and neck cancer

By sjmartinez • April 30, 2024

Shin DS, Basak S, Veena MS, Comin-Anduix B, Bhattacharya A, Dong TS, Ko A, Han P, Jacobs J, Moatamed NA, Avila L, Pellegrini M, Wang M, Srivatsan ES. Enhanced CTLA-4 blockade anti-tumor immunity with APG-157 combination in a murine head and neck cancer. Cancer Med. 2024 May;13(9):e7212. doi: 10.1002/cam4.7212. PMID: 38686626; PMCID: PMC11058674.

Tags: APG‐157, Digestive Diseases, Head and neck cancer, Hematology/Oncology, immune checkpoint inhibitors, microbiome, Publications, tumor microenvironment, Veterans Administration

Related Posts

Colorectal Cancer and Mortality Risk Among Older Adults With vs Without Adenoma on Prior Colonoscopy

Gupta S, Liu L, Demb J, Qin J, Earles A, Lamm M, Huang X, Shah SC, Chawla N, Le Y, Loeb TB, Dominitz JA, Robertson[...]

A microbiome quantitative trait locus in SLC39A8 modulates disease severity in synucleinopathy-induced models of Parkinson’s disease

Yang JC, Situ J, Troutman R, Zhu R, Black M, Buri H, Gutta A, Tian F, Kang A, Aja E, Zeng A, Lai RW, Tan[...]

A MACHINE-BASED LEARNING MODEL FOR RECURRENCE PREDICTION AND TIMING AFTER ENDOSCOPIC ERADICATION THERAPY FOR BARRETT’S ESOPHAGUS

Akshintala V, Han S, Yan Y, Bisschops R, Brennan C, Cai Y, Codipilly DC, Cotton C, Early D, Edmundowicz SA, Eluri S, Gallegos J, Goyal[...]